However, RT-qPCR-based measurements revealed that K-Ras4A accounted for 10–50% of total K-Ras in cell lines derived from colon carcinoma and melanoma, and the relative abundance of K-Ras4A was even higher in primary human tumors (Tsai et al., 2015). Here, KRAS is linked to colon carcinoma.